DFT investigations on conformational analysis, solvation effects, reactivity studies, chemical descriptors and docking of two anti‐cancerous drugs, Lenvatinib and Regorafenib
DFT investigations on conformational analysis, solvation effects, reactivity studies, chemical descriptors and docking of two anti‐cancerous drugs, Lenvatinib and Regorafenib
- July 20, 2026
- Posted by: Stemskills Lab
Vietnam Journal of Chemistry · 2022 · Cited 13 times
Jamelah S. Al‐Otaibi, Zakir Ullah, Y. Sheena Mary, Y. Shyma Mary, Sreejit Soman, M. Thirunavukkarasu, Hyung Wook Kwon
This study applies density functional theory to the anticancer drugs lenvatinib and regorafenib, covering their preferred shapes, reactive sites and solvent behaviour. Potential energy surface scans across every rotatable bond located each molecule’s lowest-energy conformation, oxygen, nitrogen and hydrogen atoms emerged as the reactive sites, and solvation free energies indicated all solvents tested were suitable except heptane. Molecular docking against several proteins gave predicted binding affinities of -8.4 to -10.5 kcal/mol for regorafenib and -7.9 to -10.1 kcal/mol for lenvatinib, reference values for others modelling how these drugs bind.
Learn these methods hands-on
This is the kind of computational work the StemSkills team publishes. Our live Molecular Modeling & MD Simulations cohort teaches you to do it yourself, mentored by published researchers.
See the bootcamp →